In some cancers, RIPK3 levels are elevated during early disease stages and inversely correlated with tumor burden and biomarkers of malignancy, suggesting a tumor‐suppressive role in the initial phases of oncogenesis [61]. The gene discussed is RIPK3; the disease is cancer.